Dissociated Anti-inflammatory Efficacy from Metabolic Adverse Effects: Strategic Evolution of Selective Glucocorticoid Receptor Modulators (SGRMs)
Authors:
- Xiaodong BaoXBXiaodong Bao
- Yuxin ZhouYZYuxin Zhou
- Jie LiJLJie Li
- Sunliang CuiSCSunliang Cui
- 14 November 2026
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
Abstract
No abstract availableThis publication has 188 references indexed in Scilit:
- EULAR recommendations for the management of systemic lupus erythematosus with kidney involvement: 2025 updateAnnals of the Rheumatic Diseases, 2025
- Vamorolone: First ApprovalDrugs, 2023
- Efficacy and Safety of ABBV‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind, Active‐Controlled Proof‐of‐Concept Phase IIa TrialArthritis & Rheumatology, 2023
- Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular DystrophyJAMA Neurology, 2022
- Alterations to Placental Glucocorticoid Receptor Expression with Alcohol ConsumptionReproductive Sciences, 2021
- Anti-inflammatory actions of Caesalpinin M2 in experimental colitis as a selective glucocoricoid receptor modulatorBiochemical Pharmacology, 2018
- VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effectsEMBO Molecular Medicine, 2013
- The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR miceMolecular Carcinogenesis, 2013
- Cross-coupling of signal transduction pathways: zinc finger meets leucine zipperTrends in Genetics, 1991
- Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase geneCell, 1987